[HTML][HTML] Biomarkers in 5q-associated spinal muscular atrophy—a narrative review

HS Lapp, M Freigang, T Hagenacker, M Weiler… - Journal of …, 2023 - Springer
Abstract 5q-associated spinal muscular atrophy (SMA) is a rare genetic disease caused by
mutations in the SMN1 gene, resulting in a loss of functional SMN protein and consecutive …

[HTML][HTML] Patient-reported prevalence of non-motor symptoms is low in adult patients suffering from 5q spinal muscular atrophy

R Günther, CD Wurster, I Cordts, JC Koch… - Frontiers in …, 2019 - frontiersin.org
Background: 5q spinal muscular atrophy (SMA) is an autosomal recessive lower
motoneuron disease caused by deletion or mutations in the survival motor neuron 1 gene …

Spinal muscular atrophy: diagnosis and management in a new therapeutic era

WD Arnold, D Kassar, JT Kissel - Muscle & nerve, 2015 - Wiley Online Library
Spinal muscular atrophy (SMA) describes a group of disorders associated with spinal motor
neuron loss. In this review we provide an update regarding the most common form of SMA …

Phenotype presentation and molecular diagnostic yield in non-5q spinal muscular atrophy

G Fernández-Eulate, J Theuriet, CJ Record… - Neurology …, 2023 - AAN Enterprises
Background and Objectives Spinal muscular atrophy (SMA) is mainly caused by
homozygous SMN1 gene deletions on 5q13. Non-5q SMA patients' series are lacking, and …

Clinical and genetic diversity of SMN1-negative proximal spinal muscular atrophies

K Peeters, T Chamova, A Jordanova - Brain, 2014 - academic.oup.com
Hereditary spinal muscular atrophy is a motor neuron disorder characterized by muscle
weakness and atrophy due to degeneration of the anterior horn cells of the spinal cord …

Biomarkers of disease progression in adolescents and adults with 5q spinal muscular atrophy: a systematic review and meta-analysis

M Gavriilaki, M Moschou, V Papaliagkas, K Notas… - Neuromuscular …, 2022 - Elsevier
Since the introduction of disease modifying treatments there is an unmet need to identify
biomarkers of spinal muscular atrophy (SMA) natural history. We performed a systematic …

Targeted sequencing with expanded gene profile enables high diagnostic yield in non‐5q‐spinal muscular atrophies

M Karakaya, M Storbeck, EA Strathmann… - Human …, 2018 - Wiley Online Library
Spinal muscular atrophies (SMAs) are a heterogeneous group of disorders characterized by
muscular atrophy, weakness, and hypotonia due to suspected lower motor neuron …

[HTML][HTML] SMA identified: clinical and molecular findings from a sponsored testing program for spinal muscular atrophy in more than 2,000 individuals

BM Bowen, R Truty, S Aradhya, SL Bristow… - Frontiers in …, 2021 - frontiersin.org
Background: Spinal muscular atrophy (SMA) linked to chromosome 5q is an inherited
progressive neuromuscular disorder with a narrow therapeutic window for optimal treatment …

[HTML][HTML] Molecular pathogenesis and new therapeutic dimensions for spinal muscular atrophy

A López-Cortés, G Echeverría-Garcés… - Biology, 2022 - mdpi.com
Simple Summary Globally, 5q spinal muscular atrophy (SMA) is one of the most common
pediatric autosomal recessive neuromuscular diseases, with a prevalence of~ 1–2 per …

[HTML][HTML] Prevalence, incidence and carrier frequency of 5q–linked spinal muscular atrophy–a literature review

IEC Verhaart, A Robertson, IJ Wilson… - Orphanet journal of rare …, 2017 - Springer
Spinal muscular atrophy linked to chromosome 5q (SMA) is a recessive, progressive,
neuromuscular disorder caused by bi-allelic mutations in the SMN1 gene, resulting in motor …